Cutler Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-53
Closed 4821
2022
Q4
$0 Hold
53
﹤0.01% 5327
2022
Q3
$1K Sell
53
-30
-36% -$1.37K ﹤0.01% 4736
2022
Q2
$3K Buy
83
+24
+41% +$1.63K ﹤0.01% 4131
2022
Q1
$5K Sell
59
-71
-55% -$7.89K ﹤0.01% 4188
2021
Q4
$19K Sell
130
-235
-64% -$52.5K ﹤0.01% 3183
2021
Q3
$91K Buy
365
+241
+194% +$82.8K ﹤0.01% 1995
2021
Q2
$57K Buy
+124
New +$53.2K ﹤0.01% 2389

Other funds holding WGS

Cutler Group's WGS Position: Q1 2023 in Review

Cutler Group sold out of GeneDx Holdings (WGS) in Q1 2023, closing a stake of 53 shares.

Cutler Group first reported a position in WGS in Q2 2021 and held it in 7 quarters. The position peaked at $91K in Q3 2021. 82 funds tracked by Wall St. Rank hold WGS as of Q1 2023.

  • Cutler Group reported no remaining GeneDx Holdings position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 53 GeneDx Holdings shares in Q1 2023.
  • Cutler Group first reported a position in GeneDx Holdings in Q2 2021 and held it in 7 quarters.
  • Cutler Group's GeneDx Holdings position peaked at $91K in Q3 2021.
  • 82 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.